- Home
- SPKL vs CMPX Comparison
SPKL vs CMPX Comparison
Compare SPKL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPKL
- CMPX
- Stock Information
- Founded
- SPKL 2021
- CMPX 2014
- Country
- SPKL United States
- CMPX United States
- Employees
- SPKL N/A
- CMPX N/A
- Industry
- SPKL
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- SPKL
- CMPX Health Care
- Exchange
- SPKL Nasdaq
- CMPX Nasdaq
- Market Cap
- SPKL 172.9M
- CMPX 206.3M
- IPO Year
- SPKL 2023
- CMPX N/A
- Fundamental
- Price
- SPKL $10.59
- CMPX $1.39
- Analyst Decision
- SPKL
- CMPX Strong Buy
- Analyst Count
- SPKL 0
- CMPX 3
- Target Price
- SPKL N/A
- CMPX $7.67
- AVG Volume (30 Days)
- SPKL 23.4K
- CMPX 450.8K
- Earning Date
- SPKL 01-01-0001
- CMPX 11-12-2024
- Dividend Yield
- SPKL N/A
- CMPX N/A
- EPS Growth
- SPKL N/A
- CMPX N/A
- EPS
- SPKL 0.19
- CMPX N/A
- Revenue
- SPKL N/A
- CMPX $850,000.00
- Revenue This Year
- SPKL N/A
- CMPX N/A
- Revenue Next Year
- SPKL N/A
- CMPX $610.48
- P/E Ratio
- SPKL $57.13
- CMPX N/A
- Revenue Growth
- SPKL N/A
- CMPX N/A
- 52 Week Low
- SPKL $10.13
- CMPX $0.77
- 52 Week High
- SPKL $11.95
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- SPKL 56.23
- CMPX 42.05
- Support Level
- SPKL $10.57
- CMPX $1.33
- Resistance Level
- SPKL $10.60
- CMPX $1.58
- Average True Range (ATR)
- SPKL 0.01
- CMPX 0.12
- MACD
- SPKL 0.00
- CMPX -0.02
- Stochastic Oscillator
- SPKL 71.43
- CMPX 18.09
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.